Skip to main content
Science laboratory test tubes , laboratory equipment
BillionPhotos.com - stock.adobe.com

Assay Development

Metabolomic Service

We continuously expand our portfolio with new assays and adapt established assays to new sample matrices. Please contact Dr. Michael Witting (Michael.Witting@helmholtz-muenchen.de) in case you are interested in particular metabolites or samples matrices that are currently not covered by our existing portfolio.

Upcoming assays, that are currently under development:

  • Central Carbon Metabolism 
  • Total Fatty Acids (GC-MS)
  • Fatty acid-hydroxy fatty acids (FAHFAs)
  • Coenzyme Q9 & Q10 (HPLC-ECD)

We use the ilab Core Management system to book services by internal and external users.  

We continuously expand our portfolio with new assays and adapt established assays to new sample matrices. Please contact Dr. Michael Witting (Michael.Witting@helmholtz-muenchen.de) in case you are interested in particular metabolites or samples matrices that are currently not covered by our existing portfolio.

Upcoming assays, that are currently under development:

  • Central Carbon Metabolism 
  • Total Fatty Acids (GC-MS)
  • Fatty acid-hydroxy fatty acids (FAHFAs)
  • Coenzyme Q9 & Q10 (HPLC-ECD)

We use the ilab Core Management system to book services by internal and external users.  

Our Contact

Membrane receptor in oncology cancer treatment, surface with the receptor within the bi lipid layer cell

Metabolomics Services Core Facility Metabolomics and Proteomics

Ingolstädter Landstraße 1 85764 Neuherberg, Building 25 and 34